summary
Introduced
07/18/2019
07/18/2019
In Committee
07/29/2019
07/29/2019
Crossed Over
07/25/2019
07/25/2019
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
191st General Court
Bill Summary
SENATE, July 18, 2019 - The committee on Ways and Means to whom was referred the Senate Bill ensuring consumer choice and equal access to eye care (Senate, No. 2278),-- reports, recommending that the same ought to pass with an amendment substituting a new draft with the same title (Senate, No. 2296).
AI Summary
This bill aims to expand the scope of practice for optometrists in Massachusetts by allowing them to use and prescribe a wider range of therapeutic pharmaceutical agents, including those in Schedules III, IV, V, and VI of Chapter 94C, for the purpose of diagnosing, preventing, correcting, managing, or treating glaucoma and other ocular abnormalities. The bill also requires optometrists to refer patients with certain conditions, such as congenital glaucoma or those requiring surgical treatment, to qualified healthcare providers. Additionally, the bill establishes a new certification process for optometrists to become qualified to utilize and prescribe these expanded therapeutic pharmaceutical agents.
Committee Categories
Budget and Finance
Sponsors (0)
No sponsors listed
Other Sponsors (1)
Senate Committee on Ways and Means (S)
Last Action
Read; and referred to the committee on House Ways and Means (on 07/29/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
Document Type | Source Location |
---|---|
State Bill Page | https://malegislature.gov/Bills/191/S2296 |
Bill | https://malegislature.gov/Bills/191/S2296.pdf |
Loading...